Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | ![]() Meditech shapes the future of vaccine storage with Breakthrough anti freezer technologyin African Countries by Solar Powered Refrigerator Technology patented by Dr Sven Kwolek Arrhenius and Dr Vipul Bumb Expands the medical refrigerator portfolio with 10 introductions. Targets USD 20 Million revenue from medical refrigerator
Taking this endeavour further, Meditech Technologies India Private Limited has expanded and strengthened its solar powered refrigerator portfolio further by launching a range of 10 new models. Keeping in mind the needs of urban and peri-urban areas where power outages are infrequent, the new series is designed with a holdover period of 3-5 days which gives sufficient time to service and fix the product in case of any downtime. The new series has been designed to offer 50% reduction in costs. In light of the limited budgets common to developing economies, this optimized series is expected to boost adoption of the superior Anti-Freeze Technology offered by Meditech Solar powered Refrigerators and solar walk in cooler. With the intent to further facilitate the government in its efforts towards 95% immunisation coverage - the mission adopted by Government for its Indradhanush program, Meditech Technologies India Private Limited has also developed an innovative standalone Solar Ice Lined Refrigerator and Solar Blood Bank refrigerator for remote health centres. Currently, for every ILR, the health center has to install a deep freezer, which calls for multiple machines to be serviced and maintained and downtime on any one affects the outreach programs significantly. Meditech combo Refrigerator freezer solution can also run on solar power - completely independently, and one such equipment can cater to 6 outreach programs in a week. This will give the government immense flexibility to set up more remote health facilities and boost actual immunisation coverage while its precision temperature control between 2-8°C will ensure maximum utilisation of vaccines. End
|
|